Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) received written notice from Janssen, a unit of Johnson & Johnson (NYSE:JNJ), to terminate their rights to JNJ-75220795, now called…
SeqLL Inc. ("SeqLL" or the "Company") (NASDAQ:SQL, SQLLW)))), a technology company providing life sciences instrumentation and research services, today announced its operating and financial